Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-24-007457

CHIEF OPERATING OFFICER sold 4,875 shares at $15.64 ($76,239)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Patel Anish · CHIEF OPERATING OFFICER

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-03-06 Sale : show line 1 in the form 10b5-1 −4,875 $15.64 $76,239 7,472 D
Open-market sales · 4,875 sh · avg $15.64 · $76,239
Loading xslF345X05/form4-03092024_120325.xml…